I agree, the full impairment charge taken now will set the company up going forward and the balance sheet is essentailly a cleanskin. Whilst the commentary is a little subdued, taking the medicine will conditions are benign sets the coy up for a return to profitability and re-rating. Bottom line - cash and minmal debt, let those royalties come home to papa.
- Forums
- ASX - By Stock
- ISS
- fy 09 results - down 1 %